Vanda Pharmaceuticals (VNDA) Enterprise Value Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.11% |
| Dec 31, 2025 | 17.32% |
| Sep 30, 2025 | 13.56% |
| Jun 30, 2025 | 9.61% |
| Mar 31, 2025 | 7.82% |
| Dec 31, 2024 | 4.70% |
| Sep 30, 2024 | 2.50% |
| Jun 30, 2024 | 0.75% |
| Mar 31, 2024 | -1.39% |
| Dec 31, 2023 | -1.83% |
| Sep 30, 2023 | -12.01% |
| Jun 30, 2023 | -12.92% |
| Mar 31, 2023 | -17.10% |
| Dec 31, 2022 | -14.36% |
| Sep 30, 2022 | -24.13% |
| Jun 30, 2022 | -16.31% |
| Mar 31, 2022 | -17.56% |
| Dec 31, 2021 | -18.92% |
| Sep 30, 2021 | -19.05% |
| Jun 30, 2021 | -19.69% |
| Mar 31, 2021 | -14.97% |
| Dec 31, 2020 | -36.87% |
| Sep 30, 2020 | -35.57% |
| Jun 30, 2020 | -35.33% |
| Mar 31, 2020 | -31.37% |
| Dec 31, 2019 | -15.64% |
| Sep 30, 2019 | -18.59% |
| Jun 30, 2019 | -27.24% |
| Mar 31, 2019 | -24.64% |
| Dec 31, 2018 | -21.59% |
| Sep 30, 2018 | -18.57% |
| Jun 30, 2018 | -16.39% |
| Mar 31, 2018 | -22.81% |
| Dec 31, 2017 | -3.37% |
| Sep 30, 2017 | -35.61% |
| Jun 30, 2017 | -29.20% |
| Mar 31, 2017 | -11.12% |
| Dec 31, 2016 | -15.69% |
| Sep 30, 2016 | -0.10% |
| Jun 30, 2016 | -9.48% |
| Mar 31, 2016 | -7.63% |
| Dec 31, 2015 | -5.95% |
| Sep 30, 2015 | -2.40% |
| Jun 30, 2015 | -0.44% |
| Mar 31, 2015 | 5.12% |
| Dec 31, 2014 | 4.46% |
| Sep 30, 2014 | 29.70% |
| Jun 30, 2014 | 30.38% |
| Mar 31, 2014 | -24.11% |
| Dec 31, 2013 | 13.01% |
| Sep 30, 2013 | -11.53% |
| Jun 30, 2013 | 10.73% |
| Dec 31, 2012 | 16.29% |